Fundamental Analysis
37 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -12.5% | +21.9% | 2 / 3 | -10.2% | -0.40 pp | -0.30 pp | +13.4% | 0.00 | 6.97 | 251 | −10,2% | 28,4 | −12,5% | 6.97 | 9.81 | −28,9% |
| Pts | 0 | 0 | 8 | 0 | 4 | 4 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 51.200 (close price on 2026-10-19)EPS (TTM): 7.343
Financial charts
1.Revenue & growth
VND bn251Q2/26
1.Revenue & growth
VND bn251Q2/26
2.Profit & growth
VND bn28,4Q2/26
3.Profit mix (Penman)
VND bn118Q2/26
4.Margins & cost structure
%12.2%Q2/26
5.Returns & cash cycle
% · days27.3%Q2/26
6.Earnings quality & cash
VND bn37,2Q2/26
7.Asset structure
VND bn954Q2/26
8.Funding & debt health
VND bn · times954Q2/26
9.Revenue backlog
VND bn0,01Q2/26
10.Valuation
times · %7,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.959Q2/26
Adjusted EPS growth, latest quarter
-12.5%
Average adjusted EPS growth, 3 quarters
21.9%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26